AB Science Announced the Continuation of the Phase 2 Study Evaluating Masitinib in Combination with Isoquercetin in COVID-19, Following the Recommendation of the Data and Safety Monitoring Board (DSMB)

By
Danielle Corrigan
-
0
282
AB Science SA announced the continuation of the Phase II study evaluating masitinib in combination with isoquercetin in COVID-19, following the recommendation of the DSMB.
[AB Science SA]
Press Release